The statements made in this article have not been evaluated by the Food and Drug Administration (FDA)
According to J&J, Tremfya is the first and only fully-human, dual-acting monoclonal antibody for UC
While slight reductions in absolute muscle mass were observed, concerns about loss-associated strength declines were addressed by observations of improved power-to-weight ratios and mobility gains in mice, alongside preserved strength in the small human cohort
Healthy Aging Longevity in the GLP-1 Era: GLP-1 and Aging For years, weight-loss and wellness advice treated the body like a simple math problem: eat less, move more, repeat
One thing you should know: GLP-1 medications slightly increase heart rate
Supporting the "cleanup" process is vital for metabolic balance